AU Patent

AU2015264861C1 — Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen

Assigned to PF Consumer Healthcare 1 LLC · Expires 2017-11-16 · 9y expired

What this patent protects

Sodium Ibuprofen Tablets And Methods Of Manufacturing Pharmaceutical Compositions Including Sodium Ibuprofen Abstract The invention broadly relates to sodium ibuprofen compositions and methods of manufacturing tablets and caplets comprising sodium ibuprofen are described. The for…

USPTO Abstract

Sodium Ibuprofen Tablets And Methods Of Manufacturing Pharmaceutical Compositions Including Sodium Ibuprofen Abstract The invention broadly relates to sodium ibuprofen compositions and methods of manufacturing tablets and caplets comprising sodium ibuprofen are described. The formulation is advantageous because it allows for the formation of tablets having low sodium content and further provides tablets exhibiting improved physical stability, high tablet hardness and high strength, coupled with excellent dissolution and bioavailability characteristics. The formulations and processes are further advantageous because they can be produced in large quantities without an unacceptable number of defective tablets.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015264861C1
Jurisdiction
AU
Classification
Expires
2017-11-16
Drug substance claim
No
Drug product claim
No
Assignee
PF Consumer Healthcare 1 LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.